News for Apollo Endosurgery, Inc. (HQ8F.F)

Print Release Apollo Endosurgery to Present at HC Wainwright Global Life Sciences Conference March 03, 2021 ... | March 3, 2021

Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.